Funding Support and Author Disclosures Dr Desai has received institutional research grants from Abbott, Alnylam, AstraZeneca, Bayer, and Novartis; and has received consulting fees from Abbott, Alnylam, AstraZeneca, Avidity Biopharma, Axon Therapeutics, Bayer, Biofourmis, Cytokinetics, GlaxoSmithKline, Medpace, Merck, New Amsterdam, Novartis, Parexel, Regeneron, River2Renal, Roche, Verily, and Veristat. Dr Petrie has received lecture, committee, or advisory board fees from AstraZeneca, Boehringer Ingelheim, Novartis, Novo Nordisk, Abbvie, Bayer, Napp, Takeda, Corvia, Cardiorentis, Pharmacosmos, Siemens, Vifor, and Eli Lilly; and has received grants from Boehringer Ingelheim, Roche, SQ Innovations, AstraZeneca, Novartis, Novo Nordisk, Medtronic, Boston Scientific, and Pharmacosmos.